[Cite as State v. Demarcia, 2023-Ohio-4617.]
IN THE COURT OF APPEALS FIRST APPELLATE DISTRICT OF OHIO HAMILTON COUNTY, OHIO
STATE OF OHIO, : APPEAL NO. C-230380 TRIAL NO. B-2301110 Plaintiff-Appellee, :
: O P I N I O N. VS. : JAMES DEMARCIA, : Defendant-Appellant. :
Criminal Appeal From: Hamilton County Court of Common Pleas
Judgment Appealed From Is: Affirmed
Date of Judgment Entry on Appeal: December 20, 2023
Melissa A. Powers, Hamilton County Prosecuting Attorney, and Alex Scott Havlin, Assistant Prosecuting Attorney, for Plaintiff-Appellee,
Raymond T. Faller, Hamilton County Public Defender, and David H. Hoffmann, Assistant Public Defender, for Defendant-Appellant. OHIO FIRST DISTRICT COURT OF APPEALS
CROUSE, Presiding Judge.
{¶1} Defendant-appellant James DeMarcia appeals from the trial court’s
entry authorizing his treating physician at Summit Behavioral Healthcare (“Summit”)
to involuntarily administer medication to DeMarcia to restore his competency. In two
assignments of error, DeMarcia argues that the trial court erred in granting a petition
for the involuntary administration of medication and challenges the trial court’s
jurisdiction to consider the petition.
I. Factual and Procedural Background
{¶2} On March 10, 2023, the Hamilton County Grand Jury issued an
indictment charging DeMarcia with three counts of felonious assault in violation of
R.C. 2903.11(A)(2), having weapons while under a disability in violation of R.C.
2923.13(A)(3), and discharge of a firearm on or near a prohibited premises in violation
of R.C. 2923.162(A)(3). The three charges of felonious assault were second-degree
felonies, while the latter two charges were both third-degree felonies. Except for the
weapons-under-disability charge, all of the charged offenses carried accompanying
firearm specifications.
{¶3} In response to a motion filed by DeMarcia’s counsel questioning his
competency, the trial court appointed the Court Forensic Services to evaluate him.
After reviewing the examiner’s report, the trial court issued an entry on June 9, 2023,
finding that DeMarcia was presently incompetent to stand trial, but that there was a
substantial probability he would become competent within one year if provided a
course of treatment. The entry ordered DeMarcia to undergo treatment at Summit for
a period not to exceed 12 months.
2 OHIO FIRST DISTRICT COURT OF APPEALS
{¶4} On June 22, 2023, Dr. Kevin P. Daly, DeMarcia’s treating physician at
Summit, filed a petition requesting that the court authorize him to involuntarily
administer medication to DeMarcia. The petition stated that DeMarcia’s primary
diagnosis was schizophrenia, that he suffered from paranoid delusions which
prohibited him from having reality-based conversations, and that medication was
necessary to restore DeMarcia to competency. The petition explained that DeMarcia
had strong views against medication and would not voluntarily medicate himself,
stating:
He believes psychiatric medications are poison and has convinced at
least one other patient to stop taking their psychiatric medications. He
does not believe he has a mental illness and refuses to take any
psychiatric medications. He does not understand the purpose of
medication and is unable to tolerate conversations about medication or
the need for treatment.
Mr. Demarcia [sic] cannot reason about the medications or discuss the
risk and benefits of the medications due to his limited insight of his
illness and inability to regulate his affect. Regarding his ability to give
or withhold informed consent, I believe that he lacks this ability. While
he can communicate a choice, he is not able to understand the relevant
information. He is not able to understand the nature of his condition or
the nature and purpose of the proposed treatment, the possible benefits
and risk of the treatment and the lack of alternative approaches to the
medication. He is unable to appreciate the situation and its
consequences. He cannot reason about treatment.
3 OHIO FIRST DISTRICT COURT OF APPEALS
{¶5} The petition listed 30 medications that Dr. Daly sought authorization to
administer to DeMarcia. This list consisted of three mood-stabilizing medications and
three medications to combat any resulting side effects of such medication; 14
antipsychotic medications and three medications to combat their potential side
effects; four medications to treat DeMarcia’s periodic agitation; and three medications
to treat insomnia caused by DeMarcia’s psychosis.
{¶6} The petition additionally set forth the potential side effects of the
various groups of medications. With respect to the mood-stabilizing medications, it
stated that one of the requested medications, Depakote, carried a risk of liver damage
and could lower a patient’s white-blood-cell count. Concerning the antipsychotic
medications, the petition explained that “[a]ll antipsychotic medications carry the risk
of metabolic syndrome including hypertension, dyslipidemia, weight gain, and
reversible diabetes in the case of the atypical agents.” It further stated that such
medications can also affect the conductivity of the heart and carry a risk of movement
disorders. But it asserted that the potential benefits of the medications outweighed
any risk, and that DeMarcia would be monitored for any adverse effects. As for the
medications used to treat insomnia, the petition stated that a potential side effect of
these medications was sedation, and that one of the requested medications had the
potential to cause a rare side effect called priapism.
{¶7} The petition further explained that not all the medications would be
administered to DeMarcia, stating that “While the list of requested medications is
extensive, the plan is not to use all the requested medications. Mr. DeMarcia would be
treated with the least amount of medication needed to effectively treat his illness. If
4 OHIO FIRST DISTRICT COURT OF APPEALS
the court granted forced medications, my plan would be to start with risperidone and
then add a mood stabilizer if indicated.”
{¶8} A hearing on the state’s petition was held on July 5, 2023. Dr. Daly
testified, offering testimony that was in accordance with the information contained in
the petition. He told the court that he was a staff psychiatrist at Summit and that he
began treating DeMarcia on June 16, 2023. Dr. Daly treated DeMarcia for six days
before filing the petition to administer medication involuntarily. He explained that he
diagnosed DeMarcia with schizophrenia, that the disease grossly impairs DeMarcia’s
judgment and behavior, and that DeMarcia has been disruptive to his ward. As an
example of this allegedly disruptive behavior, Dr. Daly explained that DeMarcia had
convinced another patient that medication is poison, causing that patient to stop
taking medication. Dr. Daly stated that he was unable to talk with DeMarcia about
medication, as DeMarcia was insistent that he did not have a mental illness and was
not interested in discussing his need for medication.
{¶9} Dr. Daly testified that all requested medications were appropriate for
schizophrenia and were approved for DeMarcia’s size, age, and weight. He stated that,
of the requested medications, DeMarcia had previously been administered Geodon,
Ativan, Benadryl, and Risperdal. Dr. Daly believed that the requested medications
would restore DeMarcia to competency, give him a better grip on reality-based
thinking, and allow him to be more cooperative with his doctor and counsel. He stated
that DeMarcia could not be restored to competency without these medications and
that DeMarcia did not have the capacity to give or withhold informed consent for
medical treatment. Dr. Daly explained that group therapy was not beneficial for
patients like DeMarcia, who have an altered sense of reality.
5 OHIO FIRST DISTRICT COURT OF APPEALS
{¶10} Dr. Daly stated that when administering medication to DeMarcia, he
would start with an antipsychotic medication, which has a calming effect and helps
people to organize their thoughts. Elaborating on which medications would be
administered, Dr. Daly stated, “Well, in psychiatry, there’s well-established first-line
treatments, second-line treatments. If those don’t work, then you go to the third line.
And so the first-line treatment for a psychotic disorder would be Risperdal as one of
them. And so I’d do that first unless they have a history of a negative reaction to it.”
{¶11} Dr. Daly was questioned on cross-examination about DeMarcia’s
history of migraine headaches. He stated that DeMarcia could receive migraine
medication even if taking Risperdal and explained that DeMarcia would be monitored
24 hours a day for any side effects. Dr. Daly was also asked to provide an example of a
delusion that DeMarcia had expressed. In response, he related that in March of 2023,
DeMarcia had gone to Christ Hospital and told the staff that unknown persons were
injecting poison into his feet while he stayed at a homeless shelter. DeMarcia further
indicated that he owned the homeless shelter where this occurred.
{¶12} At the close of the hearing, the trial court granted the petition and
authorized the involuntary administration of medication to DeMarcia. DeMarcia now
appeals from that decision.
II. Involuntary Administration of Medication
{¶13} In his first assignment of error, DeMarcia contends that the trial court
erred in granting the petition for the involuntary administration of medication.
{¶14} Ohio’s guidelines for the involuntary administration of medication to a
defendant who has been deemed incompetent to stand trial are set forth in R.C.
2945.38(B)(1)(c), which provides that:
6 OHIO FIRST DISTRICT COURT OF APPEALS
If the defendant is found incompetent to stand trial, if the chief clinical
officer of the hospital, facility, or agency where the defendant is placed,
or the managing officer or director of the institution, facility, or jail, or
the person to which the defendant is committed for treatment or
continuing evaluation and treatment under division (B)(1)(b) of this
section determines that medication is necessary to restore the
defendant’s competency to stand trial, and if the defendant lacks the
capacity to give informed consent or refuses medication, the chief
clinical officer of the hospital, facility, or agency where the defendant is
placed, or the managing officer or director of the institution, facility, or
jail, or the person to which the defendant is committed for treatment or
continuing evaluation and treatment may petition the court for
authorization for the involuntary administration of medication.
If a petition is filed in accordance with this provision, the trial court is required to hold
a hearing on the petition, after which it may “authorize the involuntary administration
of medication or may dismiss the petition.” Id.
{¶15} While R.C. 2945.38 authorizes the involuntary administration of
medication, it “does not shed light on whether a court should order involuntary
medication.” (Emphasis sic.) State v. Jefferson, 1st Dist. Hamilton No. C-200135,
2021-Ohio-2092, ¶ 5. In other words, the statute does not set forth applicable
standards to assist a trial court in determining when it is appropriate to take such
action. In the absence of such guidance, Ohio courts follow the factors set forth in Sell
v. United States, 539 U.S. 166, 123 S.Ct. 2174, 156 L.Ed.2d 197 (2003). Id.; State v.
7 OHIO FIRST DISTRICT COURT OF APPEALS
Ramey, 10th Dist. Franklin Nos. 19AP-642 and 19AP-643, 2019-Ohio-5087, ¶ 9; State
v. Brewer, 12th Dist. Clermont No. CA2008-04-040, 2008-Ohio-6193, ¶ 9-11.
{¶16} Under Sell, a trial court must make four findings before authorizing the
involuntary administration of medication: (1) “that important governmental interests
are at stake”; (2) “that forced medication will significantly further those concomitant
state interests”; (3) “that involuntary medication is necessary to further those
interests”; and (4) “that administering the drugs is medically appropriate.”
(Emphasis sic.) Sell, at paragraph two of the syllabus; see Jefferson at ¶ 5.
{¶17} DeMarcia concedes that the trial court made the required Sell findings
before authorizing the involuntary administration of medication, but he argues that
the evidence in the record does not support those findings. As we explained in
Jefferson, “we will reverse only if the trial court’s findings are against the manifest
weight of the evidence, i.e., not ‘supported by some competent, credible evidence.’ ”
Jefferson at ¶ 6, quoting Ramey at ¶ 11.
Important Government Interest
{¶18} The first Sell factor requires the trial court to find that there was an
important government interest at stake.
{¶19} “The Government’s interest in bringing to trial an individual accused of
a serious crime is important.” Sell, 539 U.S. at 180, 123 S.Ct. 2174, 156 L.Ed.2d 197.
The Sell court recognized, however, that courts “must consider the facts of the
individual case in evaluating the Government’s interest in prosecution. Special
circumstances may lessen the importance of that interest.” Id. One special
circumstance recognized in Sell was where the failure of a defendant to take
medication results in lengthy confinement in an institution for the mentally ill. Id.
8 OHIO FIRST DISTRICT COURT OF APPEALS
While clarifying that “[w]e do not mean to suggest that civil commitment is a
substitute for a criminal trial,” the court stated that “[t]he potential for future
confinement affects, but does not totally undermine, the strength of the need for
prosecution.” Id.
{¶20} Here, DeMarcia was charged with five offenses, including three second-
degree felonies and two third-degree felonies. If DeMarcia were convicted of all
offenses, and if maximum, consecutive sentences were imposed, he would face
approximately 30 years of imprisonment, and that calculation excludes any potential
application of the Reagan Tokes Law. See R.C. 2929.14(A)(2) and (3).
{¶21} While DeMarcia was ultimately indicted for five felony offenses,
complaints were initially filed in the Hamilton County Municipal Court concerning the
offenses. These complaints, which are part of the record on appeal, alleged that
DeMarcia exchanged gunfire with another individual over a public roadway, and that
during the exchange, a round of gunfire went through the front passenger door of an
occupied vehicle and into the front passenger seat.
{¶22} We have no trouble concluding that, under these circumstances,
DeMarcia was accused of serious crimes. The trial court’s finding that the government
had an important interest at stake in bringing him to trial was supported by
competent, credible evidence.
Forced Medication Will Significantly Further the State’s Interest
{¶23} The second Sell factor requires a trial court to find that involuntary
medication would significantly further the state’s interests. When considering this
factor, the trial court must make two separate inquiries. It must consider whether
“administration of the drugs is substantially likely to render the defendant competent
9 OHIO FIRST DISTRICT COURT OF APPEALS
to stand trial” and whether “administration of the drugs is substantially unlikely to
have side effects that will interfere significantly with the defendant’s ability to assist
counsel in conducting a trial defense, thereby rendering the trial unfair.” Sell, 539 U.S.
at 181, 123 S.Ct. 2174, 156 L.Ed.2d 197; Jefferson, 1st Dist. Hamilton No. C-200135,
2021-Ohio-2092, at ¶ 7. The trial court made both findings in support of its
determination that involuntary medication will significantly further the state’s
interests, and competent, credible evidence supported the findings.
{¶24} As to the first finding, Dr. Daly testified that the requested medications
would restore DeMarcia to competency, give him a better grip on reality-based
thinking, and allow him to be more cooperative with his doctor and his counsel. He
stated that the benefits of the antipsychotic medications outweighed any potential
risks.
{¶25} As to the second finding, Dr. Daly testified that DeMarcia would be
under 24-hour monitoring for the emergence of any side effects. And as set forth
above, the petition explained the potential side effects for each category of the
requested medications. DeMarcia contends that neither Dr. Daly’s testimony nor his
report addressed “the possible impact the antipsychotic medications may have on [his]
ability to communicate with his counsel.”
{¶26} While this issue was not directly addressed, it was certainly indirectly
touched on in both Dr. Daly’s testimony and the information in the report. The report
set forth the potential side effects for the antipsychotic medications, including
hypertension, dyslipidemia, weight gain, reversible diabetes, issues with the
conductivity of the heart, and movement disorders. It also stated that the benefits of
the antipsychotic medications outweighed their risks. While acknowledging these side
10 OHIO FIRST DISTRICT COURT OF APPEALS
effects, Dr. Daly testified that he believed the requested medications would restore
DeMarcia to competency and allow him to be more cooperative with his counsel. We
can accordingly infer that the antipsychotic medications would not impact DeMarcia’s
ability to communicate with his counsel, and we hold that the record contained
competent, credible evidence to support that finding. See Jefferson, 1st Dist. Hamilton
No. C-200135, 2021-Ohio-2092, at ¶ 7 (holding that although defendant’s psychiatrist
did not specifically address whether the requested medications could interfere with
his ability to communicate with his counsel, the second Sell finding was supported by
the record where the psychiatrist testified that defendant had previously taken the sole
medication that she intended to administer and had not suffered negative side effects,
that the medication would restore the defendant’s competency, and that the benefits
of the medication outweighed any possible side effects).
{¶27} DeMarcia seemingly takes issue with the fact that, while the trial court
included the findings under the second Sell factor in its entry authorizing the
involuntary administration of medication, it did not make these findings on the record
in open court. In support, he cites State v. McClelland, 10th Dist. Franklin No. 06AP-
1236, 2007-Ohio-841, and State v. Upshaw, 166 Ohio App.3d 95, 2006-Ohio-1819,
849 N.E.2d 91 (2d Dist.).
{¶28} In McClelland, the trial court failed to find that the administration of
medication was substantially unlikely to have side effects that will interfere
significantly with the defendant’s ability to assist counsel in either its oral
pronouncement or its written judgment entry. McClelland at ¶ 5. The court stated that
“because the court in Sell indicated a court must ‘find’ this sub-factor, we cannot
presume regularity in absence of an explicit finding” and that “the trial court was
11 OHIO FIRST DISTRICT COURT OF APPEALS
required to specifically find on the record that the medications were substantially
unlikely to have side effects that would interfere significantly with appellant’s ability
to assist with his defense.” Id. at ¶ 7. The court was concerned that, “without specific
findings, a thorough and appropriate appellate review of the trial court’s decision
would be impossible.” Id. at ¶ 9.
{¶29} In Upshaw, the appellate court found that the trial court failed to make
any of the required Sell findings. Upshaw at ¶ 31. While the court did not differentiate
between findings pronounced orally and findings in an entry, it stated that “[i]n the
present case, none of the above requirements were followed, nor were the appropriate
findings made.” Id.
{¶30} Unlike McClelland and Upshaw, the trial court explicitly made the
required findings in its written judgment entry, and we are able to conduct a “thorough
and appropriate” review of the trial court’s decision. See McClelland at ¶ 9. It was
sufficient for the trial court to make the findings in its written entry, as “a court speaks
only through its journal entries, not by oral pronouncements.” State v. Smith, 1st Dist.
Hamilton Nos. C-080712 and C-090505, 2009-Ohio-6932, ¶ 38.
Necessity of Medication to Further the State’s Interest
{¶31} The third Sell factor requires a trial court to determine whether
involuntary medication is necessary to further the state’s interests. With respect to this
factor, “[t]he court must find that any alternative, less intrusive treatments are
unlikely to achieve substantially the same results.” Sell, 539 U.S. at 181, 123 S.Ct. 2174,
156 L.Ed.2d 197.
{¶32} The trial court’s finding under this factor was supported by competent,
credible evidence. Dr. Daly testified that there was no lesser way to treat DeMarcia’s
12 OHIO FIRST DISTRICT COURT OF APPEALS
illness and that DeMarcia could not be restored to competency without the use of
medication. He elaborated on this point during cross-examination, stating that group
therapy does not benefit patients with an altered sense of reality like DeMarcia, and
that for patients with delusional thoughts and schizophrenia, there is not an
alternative treatment to medication.
Administration of the Medications is Medically Appropriate
{¶33} The fourth Sell factor requires the trial court to find that administration
of the medication is medically appropriate. In other words, the court must determine
whether the medication is “in the patient’s best medical interest in light of his medical
condition.” Id.
{¶34} DeMarcia argues that the trial court’s finding under this factor was not
supported by the evidence in the record because, although the trial court approved 17
antipsychotic medications, the evidence did not establish that all of the medications
were medically appropriate. He contends that the medications “warrant[ed] more
than a cursory explanation to justify them as medically appropriate.” In support of his
argument, DeMarcia relies on Upshaw, 166 Ohio App.3d 95, 2006-Ohio-1819, 849
N.E.2d 91, where an involuntary-medication order authorizing the administration of
33 medications was reversed because the record contained no evidence about the side
effects of the 33 requested medications or about what medicines or combination
thereof would actually be administered.
{¶35} This court considered a nearly identical argument in Jefferson, where
we stated:
13 OHIO FIRST DISTRICT COURT OF APPEALS
Here, Mr. Jefferson concedes that the evidence shows that Invega was
in his best medical interest, but he protests that no evidence
demonstrated that the same holds true for the other medications.
In this regard, Mr. Jefferson relies upon Upshaw, 166 Ohio App.3d 95,
2006-Ohio-1819, 849 N.E.2d 91, at ¶ 31, where the Second District
reversed an involuntary-medication order because the trial court failed
to make the necessary Sell findings and because the evidence failed to
support the trial court’s order. Although the trial court in Upshaw
authorized 33 medications in total, the record contained no evidence
about which medications would be used or their side effects. Id.
Applying Upshaw, Mr. Jefferson invites us to reverse because Dr. Doyle
did not walk through each of the non-Invega medications or explain
their potential side effects. Ultimately, we find Upshaw inapposite
because Dr. Doyle testified about which medications she planned to use
and their possible side effects. Dr. Doyle envisioned utilizing only
Invega, to which Mr. Jefferson had previously responded well. And she
further explained that she requested approval to use the other
medications only in the event that Mr. Jefferson experienced
unexpected side effects or encountered other unforeseen problems with
Invega. She also offered specific reasons for potentially using the non-
antipsychotic medications, including addressing mood swings,
insomnia, and agitation. And finally, Dr. Doyle testified that the benefits
of all the medications on her list would outweigh any possible side
14 OHIO FIRST DISTRICT COURT OF APPEALS
effects, adding that none of them have any physiological or
psychological addiction potential.
Jefferson, 1st Dist. Hamilton No. C-200135, 2021-Ohio-2092, at ¶ 9 and 10.
{¶36} The record in the case at bar is much more in line with that in Jefferson
than in Upshaw. Dr. Daly’s petition stated that his intention was not to use all the
requested medications. Rather, he planned to administer Risperdal, a drug that
DeMarcia had previously received, and to add in a mood-stabilizing medication if
necessary. The petition explained the side effects for the different categories of
medication (mood stabilizers, antipsychotic medications, medications to treat
agitation, and medications to treat insomnia). Dr. Daly’s testimony further explained
the purpose of mood-stabilizing and antipsychotic medications and the ways in which
the medications could positively impact DeMarcia. And he stated that the requested
medications were appropriate for persons suffering from schizophrenia and for
DeMarcia’s size, age, and weight.
{¶37} The record contained competent, credible evidence in support of the
trial court’s finding that administration of the requested medication was medically
appropriate. DeMarcia’s first assignment of error is accordingly overruled.
III. Jurisdiction to Entertain Petition
{¶38} In his second assignment of error, DeMarcia argues that the trial court
was without subject-matter jurisdiction to consider the petition for the involuntary
administration of medication.
{¶39} DeMarcia asserts that requirements concerning competency
determinations in R.C. 2945.38 are jurisdictional, and that when the prerequisites of
R.C. 2945.38 are not met, the trial court lacks jurisdiction to proceed. He specifically
15 OHIO FIRST DISTRICT COURT OF APPEALS
contends that the prerequisites were not met in this case because the petition for
forced medication was filed by Dr. Daly, rather than by the chief medical officer or the
director of the facility treating DeMarcia, as is required by R.C. 2945.38(B)(1)(c).
{¶40} DeMarcia’s reading of R.C. 2945.38(B)(1)(c) is inaccurate. The statute
provides in relevant part that, if a defendant has been found not competent to stand
trial:
[I]f the chief clinical officer of the hospital, facility, or agency where the
defendant is placed, or the managing officer or director of the
institution, facility, or jail, or the person to which the defendant is
committed for treatment or continuing evaluation and treatment
under division (B)(1)(b) of this section determines that medication is
necessary to restore the defendant’s competency to stand trial, and if
the defendant lacks the capacity to give informed consent or refuses
medication, the chief clinical officer of the hospital, facility, or agency
where the defendant is placed, or the managing officer or director of the
institution, facility, or jail, or the person to which the defendant is
committed for treatment or continuing evaluation and treatment may
petition the court for authorization for the involuntary administration
of medication.
(Emphasis added.) R.C. 2945.38(B)(1)(c).
{¶41} The statute plainly and unambiguously provides that “the person to
which the defendant is committed for treatment or continuing evaluation and
treatment” may petition the court for authorization to involuntarily administer
medication. It does not limit the filing of the petition to a chief medical officer or
16 OHIO FIRST DISTRICT COURT OF APPEALS
director of the treatment facility. See State v. Lanier, 10th Dist. Franklin No. 20AP-
480, 2021-Ohio-4194 (holding that the trial court did not err in granting a petition for
the involuntary administration of medication that was filed by the defendant’s
attending psychiatrist).
{¶42} In this case, the record established that Dr. Daly was the person to
whom DeMarcia was committed for treatment. Dr. Daly testified that he was a staff
psychiatrist at Summit and that he had treated DeMarcia from the date of his
admission. As DeMarcia’s treating psychiatrist, it was entirely appropriate for Dr. Daly
to have filed the petition. We accordingly hold that the trial court was not deprived of
jurisdiction to hear the petition because it was filed by a treating psychiatrist, rather
than the chief medical officer or director of Summit.
{¶43} The second assignment of error is overruled, and the judgment of the
trial court is affirmed.
Judgment affirmed.
ZAYAS and BERGERON, JJ. concur.
Please note:
The court has recorded its entry on the date of the release of this opinion.